Arcutis Biotherapeutics, Inc.ARQTNASDAQ
LOADING
|||
PB Ratio: Premium Valuation
Trending higher, above historical average.
Left:
||||
Price-to-book ratio
Latest
10.70
↑ 1777% above average
Average (7y)
-0.64
Historical baseline
Range
High:10.70
Low:-32.93
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 10.70 | +323.6% |
| 2023 | 2.52 | -35.0% |
| 2022 | 3.89 | +12.9% |
| 2021 | 3.44 | -7.2% |
| 2020 | 3.71 | -54.7% |
| 2019 | 8.18 | +124.9% |
| 2018 | -32.93 | -614.3% |
| 2017 | -4.61 | - |